Veradermics, Incorporated Financial Flexibility Index
Veradermics, Incorporated financial flexibility index. Veradermics, Incorporated (MANE) has a Financial Flexibility Index of -3.15x as of March 2026. Free cash flow of $-21.17 Million (operating CF $-21.17 Million minus capex $0.00) represents -3% of total liabilities ($6.72 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Veradermics, Incorporated (2023–2025)
Financial flexibility index of Veradermics, Incorporated from 2023 to 2025. Historical Financial Flexibility Index trend for Veradermics, Incorporated across 3 annual periods. Explore MANE operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Veradermics, Incorporated Financial Flexibility Index by Year (2023–2025)
Veradermics, Incorporated financial flexibility index by year from 2023 to 2025. Year-by-year free cash flow to debt coverage for Veradermics, Incorporated. For the full cash flow conversion analysis, see MANE cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.26x | $-71.58 Million | $-71.60 Million | $273.63 Million | ▲ +94.8% |
| 2024 | -5.02x | $-23.69 Million | $-23.69 Million | $4.72 Million | ▼ -42.6% |
| 2023 | -3.52x | $-13.51 Million | $-13.51 Million | $3.84 Million | — |